Company Profile

Nanjing Shunxiang Pharmaceutical Technology Co.,Ltd.
Year Established : 2005
Total Assets(USD) : 500,000 to 99,999,999
Total Number of Staff : 50-100
Main Competitive Advantages : Brand Name,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Small Orders Accepted,Reputation,Quality Service
Other Competitive Advantages : Considerable service and best quality DIBOC Supply.
Patents and Copyrights : Patent Technology Research DIBOC production in 2001. DIBOC technology grow into mature, realize a large-scale production in 2005. Applized for a patent with the state intellectual property office in 2006. Won the National Invention Patent of the DIBOC production process in 2009.
  • Contact Person :
  • Fax:
Nanjing Shunxiang specializes in the R & D, production, sales and information of pharmaceutical chemical intermediates. It mainly produces amino protectant series, azo series and pyridine series. The main varieties are: Di tert butyl dicarbonate (Diboc, BOC anhydride), diisopropyl azodicarbonate (DIAD), pyridinium trioxide, pyridinium tribromide, pyridine hydrochloride, Pyridinium 4-toluenesulfonate. Nanjing Shunxiang is the forerunner in the production of Di tert butyl dicarbonate. With 20 years of production experience, technological optimization and innovation and a mature production technology team, the products have been highly recognized by the market. In 2012, the company became the supplier of Novartis, Abbott, Pfizer and other international well-known enterprises. Nanjing Shunxiang is one of the leading enterprises in the production of Di tert butyl dicarbonate, the number of shipments and users in the international market has always been in the forefront. At present, the company has three production bases. With the completion and operation of Lanzhou Tengxing biological plant, the production capacity of main products will be further expanded, and provide users with stable product supply guarantee.
PharmaSources Customer Service